319 related articles for article (PubMed ID: 9618570)
1. Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging.
Deloar HM; Fujiwara T; Shidahara M; Nakamura T; Watabe H; Narita Y; Itoh M; Miyake M; Watanuki S
Eur J Nucl Med; 1998 Jun; 25(6):565-74. PubMed ID: 9618570
[TBL] [Abstract][Full Text] [Related]
2. Estimation of internal absorbed dose of L-[methyl-11C]methionine using whole-body positron emission tomography.
Deloar HM; Fujiwara T; Nakamura T; Itoh M; Imai D; Miyake M; Watanuki S
Eur J Nucl Med; 1998 Jun; 25(6):629-33. PubMed ID: 9618578
[TBL] [Abstract][Full Text] [Related]
3. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies.
Mejia AA; Nakamura T; Masatoshi I; Hatazawa J; Masaki M; Watanuki S
J Nucl Med; 1991 Apr; 32(4):699-706. PubMed ID: 2013810
[TBL] [Abstract][Full Text] [Related]
4. Internal absorbed dose estimation by a TLD method for 18F-FDG and comparison with the dose estimates from whole body PET.
Deloar HM; Fujiwara T; Shidahara M; Nakamura T; Yamadera A; Itoh M
Phys Med Biol; 1999 Feb; 44(2):595-606. PubMed ID: 10070803
[TBL] [Abstract][Full Text] [Related]
5. Estimated radiation dose to the newborn in FDG-PET studies.
Ruotsalainen U; Suhonen-Polvi H; Eronen E; Kinnala A; Bergman J; Haaparanta M; Teräs M; Solin O; Wegelius U
J Nucl Med; 1996 Feb; 37(2):387-93. PubMed ID: 8667081
[TBL] [Abstract][Full Text] [Related]
6. Internal dosimetry in F-18 FDG PET examinations based on long-time-measured organ activities using total-body PET/CT: does it make any difference from a short-time measurement?
Hu P; Lin X; Zhuo W; Tan H; Xie T; Liu G; Chen S; Chen X; Yu H; Zhang Y; Shi H; Liu H
EJNMMI Phys; 2021 Jul; 8(1):51. PubMed ID: 34264416
[TBL] [Abstract][Full Text] [Related]
7. A revision of the organ radiation doses from 2-fluoro-2-deoxy-D-glucose with reference to tumour presence.
Staaf J; Jacobsson H; Sanchez-Crespo A
Radiat Prot Dosimetry; 2012 Aug; 151(1):43-50. PubMed ID: 22247523
[TBL] [Abstract][Full Text] [Related]
8. Absorbed dose estimates in positron emission tomography studies based on the administration of 18F-labeled radiopharmaceuticals.
Mejia AA; Nakamura T; Itoh M; Hatazawa J; Ishiwata K; Ido T; Matsumoto M; Watabe H; Watanuki S; Seo S
J Radiat Res; 1991 Sep; 32(3):243-61. PubMed ID: 1838773
[TBL] [Abstract][Full Text] [Related]
9. Radiation dosimetry of beta-amyloid tracers 11C-PiB and 18F-BAY94-9172.
O'Keefe GJ; Saunder TH; Ng S; Ackerman U; Tochon-Danguy HJ; Chan JG; Gong S; Dyrks T; Lindemann S; Holl G; Dinkelborg L; Villemagne V; Rowe CC
J Nucl Med; 2009 Feb; 50(2):309-15. PubMed ID: 19164222
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
[TBL] [Abstract][Full Text] [Related]
11. Dynamic evaluation of absorbed dose to the bladder wall with a balloon-bladder phantom during a study using [(18)F]fluorodeoxyglucose positron emission imaging.
Wu TH; Liu RS; Dong SL; Chung YW; Chou KL; Lee JS
Nucl Med Commun; 2002 Aug; 23(8):749-55. PubMed ID: 12124480
[TBL] [Abstract][Full Text] [Related]
12. Estimation of organ cumulated activities and absorbed doses on intakes of several 11C labelled radiopharmaceuticals from external measurement with thermoluminescent dosimeters.
Nakamura T; Hayashi Y; Watabe H; Matsumoto M; Horikawa T; Fujiwara T; Ito M; Yanai K
Phys Med Biol; 1998 Feb; 43(2):389-405. PubMed ID: 9509534
[TBL] [Abstract][Full Text] [Related]
13. Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies.
Quinn BM; Gao Y; Mahmood U; Pandit-Taskar N; Behr G; Zanzonico P; Dauer LT
BMC Med Imaging; 2020 Jan; 20(1):9. PubMed ID: 31996149
[TBL] [Abstract][Full Text] [Related]
14. 18F-Fluoroerythronitroimidazole radiation dosimetry in cancer studies.
Tolvanen T; Lehtiö K; Kulmala J; Oikonen V; Eskola O; Bergman J; Minn H
J Nucl Med; 2002 Dec; 43(12):1674-80. PubMed ID: 12468519
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18-fluoromisonidazole radiation dosimetry in imaging studies.
Graham MM; Peterson LM; Link JM; Evans ML; Rasey JS; Koh WJ; Caldwell JH; Krohn KA
J Nucl Med; 1997 Oct; 38(10):1631-6. PubMed ID: 9379204
[TBL] [Abstract][Full Text] [Related]
16. Estimation of patient dose in (18)F-FDG and (18)F-FDOPA PET/CT examinations.
Kaushik A; Jaimini A; Tripathi M; D'Souza M; Sharma R; Mishra AK; Mondal A; Dwarakanath BS
J Cancer Res Ther; 2013; 9(3):477-83. PubMed ID: 24125986
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and radiation dosimetry of 18F-fluoro-A-85380 in healthy volunteers.
Bottlaender M; Valette H; Roumenov D; Dollé F; Coulon C; Ottaviani M; Hinnen F; Ricard M
J Nucl Med; 2003 Apr; 44(4):596-601. PubMed ID: 12679405
[TBL] [Abstract][Full Text] [Related]
18. Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
Marafi F; Esmail A; Rasheed R; Alkandari F; Usmani S
Nucl Med Commun; 2017 Sep; 38(9):764-770. PubMed ID: 28723715
[TBL] [Abstract][Full Text] [Related]
19. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.
Obrzut SL; Koren AO; Mandelkern MA; Brody AL; Hoh CK; London ED
Nucl Med Biol; 2005 Nov; 32(8):869-74. PubMed ID: 16253812
[TBL] [Abstract][Full Text] [Related]
20. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies.
Vesselle H; Grierson J; Peterson LM; Muzi M; Mankoff DA; Krohn KA
J Nucl Med; 2003 Sep; 44(9):1482-8. PubMed ID: 12960196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
